Latest filing published 13 Dec 2022 for Bellerophon Therapeutics, Inc., €4,871.
Insider track record
No signal scores available.
Nicholas Laccona: trading record in brief
Nicholas Laccona is a declared insider of Bellerophon Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 2 filings, every one of them for a trade on 9 December 2022.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 13 December 2022 with a share grant (€4,871) in Bellerophon Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Nicholas Laccona
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,530 shares@ US$0.9301100.0% of flowCommon StockSEC:0001415889-22-012502:1
- 18,000 sharesCommon StockSEC:0001415889-22-012502:0
2 of 2 declarations